Concepedia

Comparison of advanced stage mucinous epithelial ovarian cancer and serous epithelial ovarian cancer with regard to chemosensitivity and survival outcome: a matched case-control study

Emine Karabük, Mehmet Faruk Köse, Salih Taşkın, Burak Karadağ, Taner Turan, Nurettin Boran, Ahmet Özfuttu, Fırat Ortaç

Journal of Gynecologic Oncology · 2013 · 39 citations · 18 references

DOIFull text

Open access

Abstract

Advanced stage mEOC patients have more platinum resistance disease and poorer survival outcome when compared to advanced stage sEOC. Therefore, novel chemotherapy strategies are warranted to improve survival outcome in patients with mEOC.

References

18

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

William P. McGuire, William J. Hoskins, Mark F. Brady et al. · New England Journal of Medicine · 1996 · 2.9K citations · Full text

Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma.

Griffiths Ct · PubMed · 1975 · 817 citations

, , +14

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience.

G Omura, Mark F. Brady, Howard D. Homesley et al. · Journal of Clinical Oncology · 1991 · 468 citations

, , +16

Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers

John K. Chan, Deanna Teoh, Jessica M. Hu et al. · Gynecologic Oncology · 2008 · 452 citations

, , +7

Mucinous Epithelial Ovarian Cancer: A Separate Entity Requiring Specific Treatment

Viviane Hess, Roger A’Hern, Nazar Nasiri et al. · Journal of Clinical Oncology · 2004 · 325 citations · Full text